Our in vitro and in vivo experiments investigated the impact of NLRP3 on the proliferation and migration of CRC tumors and its potential correlation with the EMT process and the S6K1-GLI1 signaling pathway, providing novel insights for targeted CRC therapy. Here, RPS6KB1 is linked to colorectal carcinoma.